Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience (Q42180629)

18 October 2017

Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience (English)

1 reference

18 October 2017

1 reference

1 reference

1 reference

5

Gregory D Ayers

1 reference

18 October 2017

Chengwei Peng

1

1 reference

18 October 2017

Jialing Wang

2

1 reference

18 October 2017

Jarred P Tanksley

3

1 reference

18 October 2017

Bret C Mobley

4

1 reference

18 October 2017

Paul L Moots

6

1 reference

18 October 2017

Stephen W Clark

7

1 reference

18 October 2017

4 December 2015

1 reference

Molecular and Clinical Oncology

18 October 2017

1 reference

18 October 2017

4

1 reference

18 October 2017

154-158

1 reference

18 October 2017

2

1 reference

Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Genetic analysis of cytomegalovirus in malignant gliomas

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Hypomethylating agents and other novel strategies in myelodysplastic syndromes

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Immortal time bias in retrospective analysis: is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Valganciclovir in patients with glioblastoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Survival in patients with glioblastoma receiving valganciclovir

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

Human cytomegalovirus infection and expression in human malignant glioma.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4734189

17 August 2018

Identifiers

DOI

10.3892/MCO.2015.692

1 reference

18 October 2017

1 reference

18 October 2017

1 reference